Key result
Catheter ablation of the cavotricuspid isthmus is the primary choice for long-term therapy of typical atrial flutter, associated with >97% procedural success and 0.5% complication rates.
Catheter ablation of the cavotricuspid isthmus is highly effective and safe, representing the primary choice for long-term therapy of typical atrial flutter.
Supports CTI ablation as first-line for typical AFL; leaves open need for updated RCTs on long-term outcomes.
Typical, cavotricuspid-dependent atrial flutter is the most common atrial macroreentry tachycardia. The incidence of atrial flutter (typical and atypical forms) is age-dependent with 5/100,000 in patients less than 50 years and approximately 600/100,000 in subjects > 80 years of age. Concomitant heart failure or pulmonary disease further increases the risk of typical atrial flutter.Patients with atrial flutter may present with symptoms of palpitations, reduced exercise capacity, chest pain, or dyspnea. The risk of thromboembolism is probably similar to atrial fibrillation; therefore, the same antithrombotic prophylaxis is required in atrial flutter patients. Acutely symptomatic cases may be subjected to cardioversion or pharmacologic rate control to relieve symptoms. Catheter ablation of the cavotricuspid isthmus represents the primary choice in long-term therapy, associated with high procedural success (> 97 %) and low complication rates (0.5 %).This article represents the third part of a manuscript series designed to improve professional education in the field of cardiac electrophysiology. Mechanistic and clinical characteristics as well as management of isthmus-dependent atrial flutter are described in detail. Electrophysiological findings and catheter ablation of the arrhythmia are highlighted.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2016) conducted a review in Typical atrial flutter. Catheter ablation of the cavotricuspid isthmus was evaluated. Catheter ablation of the cavotricuspid isthmus is the primary choice for long-term therapy of typical atrial flutter, associated with >97% procedural success and 0.5% complication rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: